Migraine study seeks to match kids with best treatment
NCT ID NCT07180043
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 25 times
Summary
This study looked at 178 children aged 6 to 16 with migraine to see if certain factors could predict who would benefit from the drug propranolol versus behavioral therapy. Researchers measured changes in migraine disability and pain over 12 weeks. The goal is to help doctors choose the most effective treatment for each child.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC MIGRAINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kayseri University
Kayseri, Kayseri, 38130, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.